| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/08/2006 | EP1141254B1 Use of a xylanase for preparing a foodstuff |
| 03/08/2006 | EP1083984B1 Method for multilayered populating substrates with biological cells and populating devices that can be used therefor |
| 03/08/2006 | EP1078095B1 Viral production process |
| 03/08/2006 | EP1042457B1 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 03/08/2006 | EP1038011B1 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 03/08/2006 | EP0946730B1 Mutants of streptococcal toxin c and methods of use |
| 03/08/2006 | EP0941332B1 Carrot antifreeze polypeptides |
| 03/08/2006 | EP0920502B1 Methods and means for modifying complement activation |
| 03/08/2006 | EP0907312B1 Compositions and methods for taxol biosynthesis |
| 03/08/2006 | EP0861894B1 Differentiation-suppressive polypeptide |
| 03/08/2006 | EP0832234B1 Genetic control of flowering |
| 03/08/2006 | EP0804551B1 Bone precursor cells: compositions and methods |
| 03/08/2006 | EP0733109B1 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 03/08/2006 | EP0659216B1 Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells |
| 03/08/2006 | CN1745168A Method for culturing neural stem cells using hepatocyte growth factor |
| 03/08/2006 | CN1745104A Antibodies specific for plasmacytoid dendritic cells |
| 03/08/2006 | CN1745103A Antibody molecules having specificity for human IL-1 beta |
| 03/08/2006 | CN1745100A 因子Ⅷ多肽 Ⅷ factor polypeptides |
| 03/08/2006 | CN1745095A A method for the production of HIV-1 GAG virus-like particles |
| 03/08/2006 | CN1744913A Use of the cathelicidin LL-37 and derivatives thereof for wound healing |
| 03/08/2006 | CN1744887A Breast cancer-resistant protein inhibitor |
| 03/08/2006 | CN1744823A Engineering three-dimensional tissue structures using differentiating embryonic stem cells |
| 03/08/2006 | CN1744822A Rapid one-step method for generation of antigen loaded dendritic cell vaccine from precursors |
| 03/08/2006 | CN1744821A Methods and compositions using compounds from fetal cells and tissues to improve condition of skin |
| 03/08/2006 | CN1743456A Modulators of the function of receptors of the TNF/NGF receptor family and other protein |
| 03/08/2006 | CN1244696C Highly effective expressing method of interleukin-12 |
| 03/08/2006 | CN1244695C Novel pectate lyases |
| 03/08/2006 | CN1244691C Process of cultivating TIL cell by self hydrothorax supernatant |
| 03/08/2006 | CN1244690C Method for combined production of hair weeds polysaccharide from hair weeds cells |
| 03/08/2006 | CN1244689C Method for forming block from discreted cell of sponge organs |
| 03/07/2006 | USRE39006 Blood is sample treated with reagent, particle analyzer counts cells and gives a cell distribution profile; reagent detects immature cells without employing immunological techniques |
| 03/07/2006 | US7009094 Hybrid maize plant and seed 33V15 |
| 03/07/2006 | US7009093 produced by crossing the inbred maize line PH183 with another maize plant; resistance to diseases and insects, tolerance to heat and drought, reducing the time to crop maturity, greater yield, and better agronomic quality |
| 03/07/2006 | US7009087 nucleotide molecules comprising sequences for thioredoxin h and NADPH-thioredoxin reductase; can be used to transform plants alone or in combination with other sequences to manipulate thioredoxin h system and alter protein disulfide status |
| 03/07/2006 | US7009040 Administering a monoclonal antibody encoded by a clone on deposit which binds specifically to an antigen expressed by a tumor; screening for cancerous cells; biological conjugation with a radioisotope, enzyme toxins and hematogenous cells; antitumor agents; anticarcinogenic agents; cytotoxicity |
| 03/07/2006 | US7009039 obtained by mixing plasma proteins fibrinogen and Factor XIII with thrombin and at least one anti-fibrinolytic agent (tranexamic acid) in absence of organic chelating agent; implant for tissue engineering |
| 03/07/2006 | US7009035 Peptide for use in the diagnosis and treatment of tumors |
| 03/07/2006 | US7008922 Transplantation antigen that can lead to rejection of HLA-matched male organ and bone marrow grafts by female recipients, and may play a role in pregnancy and spermatogenesis. However, the origin and function of H-Y |
| 03/07/2006 | US7008921 Materials and methods relating to endothelial cell growth inhibitors |
| 03/07/2006 | US7008790 Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae |
| 03/07/2006 | US7008783 Nucleic acid sequences coding for chondroitinase ABC gene and isolated chondroitinase ABC protein produced in a host cell transformed with a nucleic acid vector directing the expression of a nucleotide sequence coding for chondroitinase ABC |
| 03/07/2006 | US7008782 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of preferential genetic disorder |
| 03/07/2006 | US7008781 Method of enhancing the biological activity of ligands |
| 03/07/2006 | US7008780 Chimeric DNA-binding proteins |
| 03/07/2006 | US7008779 novel gene and protein designated PHELIX; in normal individuals, expressed only in testis, but expressed at high levels in advanced and metastatic prostate cancer, and expressed at lower levels in testicular, bladder, ovarian cancers |
| 03/07/2006 | US7008778 Breast cancer specific gene 1 |
| 03/07/2006 | US7008767 Cloning preferential genes; obtain cells, transform, express preferential genes in cells, monitor activity of genes in biosynthetic process |
| 03/07/2006 | US7008765 polynucleotides that code for prostate specific antigen proteins or polypeptides; cells containing the recombinant nucleic acid molecules; hybridomas containing the antibodies; kits containing probes or antibodies; prevention of prostate cancer |
| 03/07/2006 | US7008764 Optimization of cells for endogenous gene activation |
| 03/07/2006 | US7008763 Method to treat collagenous connective tissue for implant remodeled by host cells into living tissue |
| 03/07/2006 | US7008664 Method for improving the carcass quality of an animal |
| 03/07/2006 | US7008634 includes growth factors and extracellular matrix molecules flexibly tethered to a support medium; used to stimulate cell and tissue growth by enhancment of the biological response to the growth factor; liver cells |
| 03/07/2006 | US7008622 Methods and compositions for impairing multiplication of HIV-1 |
| 03/02/2006 | WO2006024041A2 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 03/02/2006 | WO2006023502A2 Particle/cell separation device and compositions |
| 03/02/2006 | WO2006023422A2 Stem-like cells |
| 03/02/2006 | WO2006023148A2 Genetically modified human natural killer cell lines |
| 03/02/2006 | WO2006023136A2 A neural stem cell-collagen-bioreactor system to construct a functional embryonic brain-like tissue |
| 03/02/2006 | WO2006022958A1 Method and apparatus for substantially isolating plant tissues |
| 03/02/2006 | WO2006022671A1 Method for in situ repair of injured, damaged, diseased or aged articular cartilage using neo-cartilage constructs and a method for preparation thereof |
| 03/02/2006 | WO2006022612A2 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| 03/02/2006 | WO2006022422A1 Modified human hepatitis c virus genomic rna having autonomous replicative competence |
| 03/02/2006 | WO2006022377A1 Method of selecting myocardial cells by using intracellular mitochondria as indication |
| 03/02/2006 | WO2006022361A1 Psf1 GENE-DEFICIENT ANIMAL AND METHOD OF USING THE SAME |
| 03/02/2006 | WO2006022330A1 Method of producing dendritic cell from prrimate embryonic stem cell |
| 03/02/2006 | WO2006022263A1 Medium for the redifferentiation of dedifferentiated chondrocytes into chondrocytes |
| 03/02/2006 | WO2006022091A1 Method of culturing human bone marrow-origin mesenchymal stem cells using human serum medium |
| 03/02/2006 | WO2006021950A1 Methods of generating embryoid bodies using three dimensional scaffolds |
| 03/02/2006 | WO2006021460A1 Means and methods for generating cardiomyocytes and tissue and uses thereof |
| 03/02/2006 | WO2006021210A2 Binding member towards pneumolysin |
| 03/02/2006 | WO2006011815A3 Phosphatases, polynucleotides encoding these and uses thereof |
| 03/02/2006 | WO2006006273A8 Dendritic cell activator |
| 03/02/2006 | WO2006002170A3 Resistance to verticillium 2 in tomato |
| 03/02/2006 | WO2005123123A3 Therapeutic reprogramming, hybrid stem cells and maturation |
| 03/02/2006 | WO2005113590A3 Bmp10 propeptides and related methods |
| 03/02/2006 | WO2005111121A3 Method for producing shaped bodies made from crosslinked gelatine |
| 03/02/2006 | WO2005072388A3 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone |
| 03/02/2006 | WO2005068622A3 Mixtures of binding proteins |
| 03/02/2006 | WO2005040379A3 RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/02/2006 | WO2005026326A3 Generation of chicken cell lines from embryonic stem cells and germ cells |
| 03/02/2006 | WO2005019429A3 Compositions and methods for enhancing phagocytosis or phagocyte activity |
| 03/02/2006 | WO2005012527A9 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 03/02/2006 | WO2005012513A8 Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regenaration |
| 03/02/2006 | WO2004057940A3 Canine dioxin/aryl hydrocarbon receptor sequences |
| 03/02/2006 | WO2004016758A3 Brain endothelial cell expression patterns |
| 03/02/2006 | WO2003039232A3 Endothelial cell derived hemotopoietic growth factor |
| 03/02/2006 | WO2002072769A3 Human serpin polypeptides |
| 03/02/2006 | US20060048246 Development of transgenic plants; transient assay, genetic engineering |
| 03/02/2006 | US20060048243 Inbred maize line NP2460 |
| 03/02/2006 | US20060048241 A novel recombinant vector isolated from Arabidopsis thaliana comprising the plant senescence-specific gene along with the promoter, and a transgenic plant species transformed with the recombinant vector |
| 03/02/2006 | US20060048239 Plants having modified growth characteristics and a method for making the same |
| 03/02/2006 | US20060048238 Transgenic tieg non-human animals |
| 03/02/2006 | US20060046295 Helper virus-free AAV production |
| 03/02/2006 | US20060046293 Dopaminergic Nurr1-positive neuron stem cells, pharmaceutical composition therefor, and methods for isolation, culture and preservation thereof |
| 03/02/2006 | US20060046284 BGL4 beta-glucosidase and nucleic acids encoding the same |
| 03/02/2006 | US20060046249 Identification of polynucleotides and polypetide for predicting activity of compounds that interact with protein tyrosine kinase and or protein tyrosine kinase pathways |
| 03/02/2006 | US20060046247 Protecting avians from pathogens |
| 03/02/2006 | US20060045878 Pancreas-derived plasminogen activator inhibitor |
| 03/02/2006 | US20060045876 Fusion proteins of humanized g250 specific antibodies and uses thereof |
| 03/02/2006 | US20060045872 Use of adipose tissue-derived stromal stem cells in treating fistula |